Cycling back to folate metabolism in cancer
Top Cited Papers
Open Access
- 2 May 2024
- journal article
- review article
- Published by Springer Nature in Nature Cancer
- Vol. 5 (5) , 701-715
Abstract
Metabolic changes contribute to cancer initiation and progression through effects on cancer cells, the tumor microenvironment and whole-body metabolism. Alterations in serine metabolism and the control of one-carbon cycles have emerged as critical for the development of many tumor types. In this Review, we focus on the mitochondrial folate cycle. We discuss recent evidence that, in addition to supporting nucleotide synthesis, mitochondrial folate metabolism also contributes to metastasis through support of antioxidant defense, mitochondrial protein synthesis and the overflow of excess formate. These observations offer potential therapeutic opportunities, including the modulation of formate metabolism through dietary interventions and the use of circulating folate cycle metabolites as biomarkers for cancer detection.Keywords
This publication has 198 references indexed in Scilit:
- Binding Modes of Xanthine‐Derived Selective Allosteric Site Inhibitors of MTHFD2ChemistryOpen, 2023
- Mitochondrial DNA mutations in ageing and cancerMolecular Oncology, 2022
- The First Structure of Human MTHFD2L and Its Implications for the Development of Isoform‐Selective InhibitorsChemMedChem, 2022
- Discovery of PHGDH inhibitors by virtual screening and preliminary structure–activity relationship studyBioorganic Chemistry, 2022
- Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitorsCellular and Molecular Life Sciences, 2021
- Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profilingActa Pharmaceutica Sinica B, 2021
- Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenaseBioorganic Chemistry, 2019
- Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT2 by antifolate drugsFEBS Letters, 2019
- Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogrammingBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2016
- The metabotropic glutamate receptor antagonist l-2-amino-3-phosphonopropionic acid inhibits phosphoserine phosphataseEuropean Journal of Pharmacology, 1996